{
    "2021-12-22": [
        [
            {
                "time": "2021-12-21",
                "original_text": "医药行业周报：CXO及创新药板块短期受事件因素扰动 赛道性性价比逐渐突出",
                "features": {
                    "keywords": [
                        "CXO",
                        "创新药",
                        "事件因素",
                        "赛道性性价比"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-21",
                "original_text": "恒瑞医药现2笔大宗交易 总成交金额3577.40万元",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "大宗交易",
                        "成交金额"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-12-21",
                "original_text": "孙飘扬复出140天，“药茅”有变",
                "features": {
                    "keywords": [
                        "孙飘扬",
                        "复出",
                        "药茅"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-21",
                "original_text": "恒瑞医药今日大宗交易成交25万股，成交价50.0元溢价0.68%",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "大宗交易",
                        "溢价"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-21",
                "original_text": "掘金创新药｜腾盛博药贡献首款国产新冠特效药：全球已有7款同类药物上市 市场机遇集中在海外",
                "features": {
                    "keywords": [
                        "创新药",
                        "腾盛博药",
                        "新冠特效药",
                        "海外市场"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-21",
                "original_text": "恒瑞医药皮下注射PD-1药物进入临床试验阶段，抗肿瘤药物竞争开始“进阶”",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "PD-1",
                        "临床试验",
                        "抗肿瘤药物"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-21",
                "original_text": "超5亿元新一代抗凝药物市场，迎来新入局者",
                "features": {
                    "keywords": [
                        "抗凝药物",
                        "市场",
                        "新入局者"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-21",
                "original_text": "华东医药、人福医药等多药企昨遭北向资金席位净流入",
                "features": {
                    "keywords": [
                        "华东医药",
                        "人福医药",
                        "北向资金",
                        "净流入"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-21",
                "original_text": "A股融资融券日报：两融余额减少7.19亿元（12月21日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额",
                        "减少"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "整体市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}